av/medigene-ag--big.svg

COM:MEDIGENE

Medigene AG

  • Stock

Last Close

1.61

22/11 16:36

Market Cap

33.01M

Beta: -

Volume Today

13.81K

Avg: -

  • market

    STOCKS
  • industry

    Healthcare & Health Services
  • website

    medigene.com
  • crunchbase

    medigene
  • ipo date

    Jun 30, 2000

Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company is developing personalized T cell-based therapies with a focus on T cell receptor-modified T cells in the areas of unmet medical needs, which are in clinical development. It also focuses on dendritic cell vaccines and T cell-specific monoclonal ant...Show More

competitor of